Acneiform Eruptions: Clinical Trials

7 trials for Acneiform Eruptions, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 terminated. 7 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 27Terminated 7

Follow Acneiform Eruptions: new trials by email Literature Review of Acneiform Eruptions trials Research Report on Acneiform Eruptions

Trials (filtered) newest first · largest first

All 7 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
LiftActiv B3 in Post Inflammatory Hyperpigmentation (PIHP)
Liftactiv B3, Sunscreen - Acne, Post Inflammatory Hyperpigmentation
Phase 2TerminatedUniversity of Miami132022-03-222024-04-03
A Study to Evaluate of the Efficacy and Safety of Imsidolimab (ANB019) in the Treatment of Acneiform Rash
Imsidolimab, Placebo - Acneiform Eruptions
Phase 2TerminatedVanda Pharmaceuticals42021-05-042025-09-22
Evaluation of Topical Application of BMX-010 in Subjects With Acne Vulgaris.
BMX-010 0.3% - Acne Vulgaris
Phase 2TerminatedBioMimetix JV, LLC22019-01-032023-09-21
MLE4901 vs. Placebo for the Treatment of PCOS
MLE4901, Placebo - Polycystic Ovary Syndrome (PCOS)
Phase 2TerminatedMillendo Therapeutics US, Inc.552016-07-012021-02-01
Apremilast in the Treatment of Moderate to Severe Acne
apremilast - Acne
Phase 2TerminatedUniversity of North Carolina, Chapel Hill32010-02-012017-03-13
Safety and Efficacy of the Use of Botox on Acne
Botulinum Neurotoxin Type A, Bacteriostatic saline - Acne Vulgaris
Phase 2TerminatedDeNova Research52008-09-012018-06-29
Pilot Study of a Dietary Intervention to Prevent Acne Recurrence
Minimization of milk and dairy products in the diet - Acne
Phase 2TerminatedHarvard School of Public Health (HSPH)302005-08-012006-09-21

Narrower conditions

Acne Vulgaris (6)  ·  Alopecia (1)  ·  Hirsutism (1)  ·  Hyperpigmentation (1)  ·  Menstruation Disturbances (1)  ·  Polycystic Ovary Syndrome (1)

Broader conditions

Skin Diseases (7)  ·  Skin and Connective Tissue Diseases (7)  ·  Sebaceous Gland Diseases (6)  ·  Adnexal Diseases (1)  ·  Cysts (1)  ·  Endocrine System Diseases (1)  ·  Female Urogenital Diseases (1)  ·  Female Urogenital Diseases and Pregnancy Complications (1)  ·  Genital Diseases (1)  ·  Genital Diseases, Female (1)  ·  Gonadal Disorders (1)  ·  Hair Diseases (1)  ·  Hypotrichosis (1)  ·  Neoplasms (1)

Interventions

Botulinum Toxins, Type A (1)  ·  Dairy Products (1)  ·  Sunscreening Agents (1)  ·  apremilast (1)

Sponsors

BioMimetix JV, LLC (1)  ·  DeNova Research (1)  ·  Harvard School of Public Health (HSPH) (1)  ·  Millendo Therapeutics US, Inc. (1)  ·  University of Miami (1)  ·  University of North Carolina, Chapel Hill (1)  ·  Vanda Pharmaceuticals (1)

Countries

United States (6)  ·  Czechia (1)  ·  Georgia (1)  ·  Latvia (1)  ·  Poland (1)  ·  United Kingdom (1)

Top investigators

Aida Lugo-Somolinos, MD (1)  ·  F. William Danby, MD, FRCPC (1)  ·  Jorge E Chavarro, MD, SM (1)  ·  Steven H Dayan, MD F.A.C.S. (1)  ·  Walter C Willett, MD, DrPH (1)

NIH funding

2016 (1)